anti-C5A (C5a) Antikörper

Bezeichnung:: anti-Complement Component 5a Antikörper (C5a)

Auf www.antikoerper-online.de finden Sie aktuell 61 Complement Component 5a (C5a) Antikörper von 10 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen C5A Kits (104) und C5A Proteine (21) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 187 C5A Produkte verfügbar.

Synonyme:: C5a, C5b, CPAMD4, Hc, RGD1561905

Alle Antikörper anzeigen	Gen	GeneID	UniProt
	C5a	727	P01031
	C5a	362119
	C5a
Alle Spezies anzeigen Weitere Synonyme anzeigen

Meistgesuchte Reaktivitäten zu anti-C5A (C5a) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Human C5A Antikörper:

anti-Rat (Rattus) C5A Antikörper:

anti-Mouse (Murine) C5A Antikörper:

Alle verfügbaren anti-C5A Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Verknüpfte Pathways mit anti-C5A Antikörper

Weitere Produktkategorien zu C5A Antikörper

Am meisten referenzierte anti-C5A Antikörper

Mouse (Murine) Monoclonal C5A Primary Antibody für ELISA - ABIN2688862 : Hugli: Structure and function of the anaphylatoxins. in Springer seminars in immunopathology 1984 (PubMed)

Weitere Antikörper gegen C5A Interaktionspartner

Human Complement Component 5a (C5a) Interaktionspartner

recombinant C5a potentiated TNFalpha (zeige TNF Antikörper)-induced NF-kappaB (zeige NFKB1 Antikörper) activation in renal tubular epithelial cells
tumoral C5a is an independent adverse prognostic biomarker for clinical outcome of Clear Cell Renal Cell Carcinoma (zeige MOK Antikörper) patients after nephectomy.
C5a synergises with P. aeruginosa LPS (zeige IRF6 Antikörper) in both PD-L1 (zeige CD274 Antikörper) expression and the production of IL-10 (zeige IL10 Antikörper) and TGF-beta (zeige TGFB1 Antikörper).
Up-regulation of granulocyte and monocyte CD11b (zeige ITGAM Antikörper) during plasma separation was C5-dependent.
This study provides the preclinical rationale for the combined blockade of PD-1 (zeige PDCD1 Antikörper)/PD-L1 (zeige CD274 Antikörper) and C5a to restore antitumor immune responses, inhibit tumor cell growth, and improve outcomes of patients with lung cancer
Diagnosis and therapeutic management of neonatal hemochromatosis (zeige HFE Antikörper) cannot only be based on C5b9 expression in liver samples as it is not specific of this disease.
C5a-C5aR enriched clear cell renal cell carcinoma (zeige MOK Antikörper) patients significantly had a poorer overall survival and recurrence free survival after nephrectomy.
The complement activation factors Bb, C3a, C5a, and MAC were increased significantly in early-onset severe pre-eclampsia (EOSPE) (all P<.01) and late-onset severe pre-eclampsia (LOSPE). (P value: .027, <.001, .001, and <.001, respectively) compared with E/L-control. C1q and C4d were increased significantly in LOSPE (P value: .003 and .014, respectively) compared with L-control.
C5a/C5aR pathway promotes gastric cancer pathogenesis by suppressing p21 (zeige CDKN1A Antikörper)/p-p21 (zeige CDKN1A Antikörper) expression via activation of PI3K (zeige PIK3CA Antikörper)/AKT (zeige AKT1 Antikörper) signaling.
Studies indicate that the complement response lie the active fragments, C3a (zeige C3 Antikörper) and C5a, acting through their specific receptors, C3aR (zeige C3AR1 Antikörper), C5aR1 (zeige C5AR1 Antikörper) and C5aR2 to direct the cellular response to inflammation.

C5A (C5a) Antigen-Profil

Beschreibung des Gens

The protein encoded by this gene is the fifth component of complement, which plays an important role in inflammatory and cell killing processes. This protein is comprised of alpha and beta polypeptide chains that are linked by a disulfide bridge. An activation peptide, C5a, which is an anaphylatoxin that possesses potent spasmogenic and chemotactic activity, is derived from the alpha polypeptide via cleavage with a convertase. The C5b macromolecular cleavage product can form a complex with the C6 complement component, and this complex is the basis for formation of the membrane attack complex, which includes additional complement components. Mutations in this gene cause complement component 5 deficiency, a disease where patients show a propensity for severe recurrent infections. Defects in this gene have also been linked to a susceptibility to liver fibrosis and to rheumatoid arthritis.

Alternative names and synonyms associated with C5A (C5a)

complement C5 (C5) Antikörper

C5a Antikörper
C5b Antikörper
CPAMD4 Antikörper
Hc Antikörper
RGD1561905 Antikörper

Bezeichner auf Proteinebene für C5a

C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4 , C5a anaphylatoxin , anaphylatoxin C5a analog , complement C5 , prepro-C5 , anaphylatoxin

GENE ID	SPEZIES
727	Homo sapiens
362119	Rattus norvegicus

Ausgewählte Anbieter für anti-C5A (C5a) Antikörper

Haben Sie etwas anderes gesucht?

Telefon:	+1 877 302 8632
Fax:	+1 888 205 9894 (Toll-free)
E-Mail:	orders@antikoerper-online.de

Show all anti-Complement Component 5a (C5a) Antikörper with Pubmed References

Human Complement Component 5a (C5a) Interaktionspartner

Beschreibung des Gens

Alternative names and synonyms associated with C5A (C5a)

Bezeichner auf Proteinebene für C5a